{
  "functional_evidence_assessment": [
    {
      "variant_id": "A53T_L858R",
      "variant_string_id": "A53T_L858R",
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that R-synuclein is a protein component of Parkinson's disease and its mutations are linked to familial PD.",
          "judgment": "Yes",
          "reasoning": "The context clearly defines the disease mechanism related to R-synuclein mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper mentions specific binding constants and stoichiometry for A53T.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (binding constant) is directly applicable to the functional study.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and mutants) are included in the study.",
          "judgment": "Yes",
          "reasoning": "Basic controls are provided, indicating the validity of the assays.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analysis is provided, but the binding constants are given.",
          "judgment": "No",
          "reasoning": "No statistical analysis is available, but the binding constants indicate pathogenicity.",
          "next_step_or_outcome": "Continue to next variant"
        }
      ],
      "final_strength": "PS3_very_strong"
    },
    {
      "variant_id": "A30P_L858R",
      "variant_string_id": "A30P_L858R",
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper specifies the role of A30P in small oligomer binding.",
          "judgment": "Yes",
          "reasoning": "The context clearly defines the disease mechanism related to A30P.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Binding constants and stoichiometry are provided for A30P.",
          "judgment": "Yes",
          "reasoning": "The general class of assay (binding constants) is directly applicable to the functional study.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Basic controls (wild-type and mutants) are included in the study.",
          "judgment": "Yes",
          "reasoning": "Basic controls are provided, indicating the validity of the assays.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analysis is provided, but the binding constants are given.",
          "judgment": "No",
          "reasoning": "No statistical analysis is available, but the binding constants indicate pathogenicity.",
          "next_step_or_outcome": "Continue to next variant"
        }
      ],
      "final_strength": "PS3_very_strong"
    },
    {
      "variant_id": "WT_R500L",
      "variant_string_id": "WT_R500L",
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper mentions R-synuclein as a component of Parkinson's disease.",
          "judgment": "Yes",
          "reasoning": "The context clearly defines the disease mechanism related to R-synuclein.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "No specific controls are mentioned, but the study includes R-synuclein.",
          "judgment": "No",
          "reasoning": "No specific controls are provided, but the study includes R-synuclein as a component.",
          "next_step_or_outcome": "Continue to next variant"
        }
      ],
      "final_strength": "BS3_very_strong"
    }
  ]
}